Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Mounjaro doesn't typically cause withdrawal symptoms in the way some medicines do, but many people do notice changes — particularly around appetite, weight, and how they feel day to day. Understanding what's likely, what's less certain, and what needs a prescriber's input is the decision this page helps you think through. Mounjaro (tirzepatide) is a prescription-only medicine; any decision to stop, pause or alter your treatment should be made with your prescribing team, never unilaterally. Our free consultation includes a full discussion of how treatment ends as well as how it begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One misconception that surfaces regularly is that stopping Mounjaro triggers a physical withdrawal state similar to coming off antidepressants or corticosteroids. That's not quite accurate, and it's worth letting go of gently. Tirzepatide isn't habit-forming in that sense; it doesn't create physiological dependence in the classic way.
What it does do is actively suppress appetite and slow gastric emptying while it's in your system. As the medicine clears (tirzepatide has a half-life of roughly five days, so meaningful clearance takes several weeks) those effects reverse. Hunger signals return. Food may feel less filling. For some people this happens gradually; for others it feels abrupt, particularly if they stop at a higher dose. The broader side-effect profile of Mounjaro is worth reading alongside this page, because understanding what the medicine does helps explain what happens when it stops.
The GI symptoms that many people find difficult during dose increases (nausea, reflux, loose stools) typically ease as the medicine leaves the body. That's generally welcome. If you want a fuller picture of what to expect during treatment itself, our page covering what the side effects of taking Mounjaro are actually like explains those effects in detail. The appetite suppression, though, leaves with it. Recognising these as separate things matters when you're planning how to stop.
The NHS tirzepatide medicine page is a reliable starting point for information about how tirzepatide works and what to expect when treatment changes.
This is the section most people are actually asking about, even if the search query doesn't say so. SURMOUNT-1 and subsequent tirzepatide trial data make clear that weight regain after stopping is common and measurable. It mirrors what's been seen with semaglutide and other GLP-1 medicines: a significant proportion of lost weight tends to return within a year of stopping, with the rate depending on factors including how long treatment lasted, which dose was reached, and what lifestyle habits were in place.
That evidence isn't a reason to feel defeated. It reflects genuine biology: the mechanisms that made it harder to maintain a lower weight before treatment reassert themselves once the medicine is gone. A prescriber can factor this into the plan, whether that means a structured taper, a planned break with a return to treatment, or transitioning to a different approach. Those options are worth discussing before stopping rather than after.
For context on the longer picture, our page on Mounjaro's long-term side effects covers what the trial data shows over extended periods.
Nutrition matters more here than at any other point in treatment. Protein adequacy and keeping activity levels stable during the weeks after stopping helps slow the pace of any regain. Personal targets should be agreed with your prescriber or a dietitian, not drawn from general population guidance.
Stopping Mounjaro isn't usually a medical emergency. Most people taper off without incident. There are, however, situations that need prompt attention regardless of whether you're in the process of stopping or have already done so.
Seek urgent help for severe or persistent stomach pain, especially if it reaches through to your back, this can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but potentially serious effect of GLP-1 medicines. Gallbladder-related symptoms such as sharp right-sided abdominal pain after eating, or pain that comes with fever and nausea, also warrant same-day assessment.
Signs of an allergic reaction (swelling of the face or throat, difficulty breathing, severe skin reaction) need emergency care immediately. Persistent vomiting severe enough to prevent you keeping fluids down can cause dehydration quickly, particularly in older adults; don't wait on that one.
For concerns that are worrying but not acute, your GP is the right first call. If you're a nume patient, our prescribers are available for aftercare seven days a week. Our support team can triage your question to the right person. And if you notice something unexpected after stopping, you can report it directly to the MHRA at the Yellow Card scheme, that data genuinely shapes future safety guidance.
The decision to come off Mounjaro deserves as much clinical thought as the decision to start. People arrive at it for different reasons: they've hit their goal weight, treatment has run its planned course, side effects became unmanageable, circumstances changed, or the cost no longer fits. None of those reasons is wrong. The process of stopping well is what varies.
A planned pause or end to treatment is different from running out of pens without a repeat in place. The former gives you time to prepare, to review your eating habits, get lifestyle support in place, and understand what the weeks ahead are likely to feel like, including which side effects coming off Mounjaro are commonly reported and what tends to resolve on its own. The latter tends to feel more disorienting. Our Mounjaro overview explains how the treatment is structured from start through to repeat prescribing.
If you're weighing whether Mounjaro is right for you at all (whether to start, continue or stop) exploring the risks and considerations alongside this page gives a more complete picture. Speak to our prescribers as part of your consultation; suitability for starting and for stopping are both part of the clinical conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.